Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟡 Modified
We face risks related to the personal data we collect, process, and share.
🔒
🟡 Modified
Our or our collaborators' failure to meet the stringent requirements of governmental regulation in the manufacture of drug products or product candidates could result in incurring substantial remedial costs, delays in the development or approval of our product candidates or new indications for our marketed products and/or in their commercial launch if regulatory approval is obtained, and a reduction in sales.
🔒
🟡 Modified
If we are unable to establish sufficient commercial capabilities outside the United States for products we intend to commercialize or co-commercialize outside the United States, our business, prospects, operating results, and financial condition may be adversely affected.
🔒
🟡 Modified
We are substantially dependent on the success of EYLEA, EYLEA HD, and Dupixent.
🔒
🟡 Modified
There can be no assurance that we will continue to repurchase shares of our Common Stock or continue to declare cash dividends.
🔒